Where are we with drug-coated balloons (DCB) in PCI? Five thoughts. 1) The use of DCB in patients with in-stent restenosis, especially of a bare metal stent, is well established and evidence-based (now also in the US). 2) Conversely, DCB use in de novo disease lacks compelling

😂

I'm attending TCT 2024 in Washington, DC, October 27-30! Join me! tct2024.crfconnect.com

Calcified lesions are high risk for intervention.

Ancient Greek thinkers like Socrates and Plato hated democratic elections. They saw democracy as part of an endless cycle of regimes — destined to slip into mob rule. But Polybius knew how to break the cycle... (thread) 🧵

Ten ethical ways to use ChatGPT for academic purposes that do not involve any plagiarism:

Recently published. Comparison of Fixed Dose Versus Weight-Adjusted Heparin on the Prevention of Radial Artery Occlusion After Diagnostic Transradial Catheterization hmpgloballearningnetwork.com/site/jic/origi…

Is complete revascularization in STEMI different from NSTEMI? "It is possible that an “incorrect” culprit could be treated in the setting of an NSTEMI, which would lead to worse outcomes if the true culprit lesion was left untreated." sciencedirect.com/science/articl…

Now in Early View ➡️ hmpgloballearningnetwork.com/site/jic/origi… Roberto Léo da Silva Dr. Deepak L. Bhatt #cardioTwitter #cardioX #cardiology #interventionalcardiology

Radial or Femoral? Transradial access (TRA) is gaining ground. Why? Compared to femoral access (TFA), TRA offers: ✅ Lower Bleeding & Vascular Complications – Significantly reducing access site complications. A safer choice for many patients. ✅ Faster Recovery & Ambulation –

Always an important remider.

🔖The June issue is live! Read here: hubs.ly/Q03qL_jy0 Dr. Deepak L. Bhatt #cardioTwitter #cardioX #cardiology #interventionalcardiology Roberto Léo da Silva Heberto A. Bruno Quentin Landolff Deniz Mutlu Center for Coronary Artery Disease Yader Sandoval Emmanouil Brilakis Devika Aggarwal

Nothing new on the front: patent (and short) hemostasis and heparin (no need for high doses): Newer Emerging Strategies to Reduce Radial Artery Occlusion: Post-Transradial Catheterization scai.org/quality-improv…

Another NEJM article on fluids. We keep burning years and millions of dollars on the wrong questions. Another massive trial to compare one bag of saltwater to another, as if the problem in fluid resuscitation is the label instead of the why, the how, and the how much. It’s no

Fibrinolytic therapy remains a major mgmt option for thromboembolic diseases. Advances in catheter-directed techniques, dosing strategies, & novel agents may expand therapeutic options & improve the safety of fibrinolytic therapy. jacc.org/doi/10.1016/j.… #JACC Behnood Bikdeli Harlan Krumholz

The DOSE Trial: In a multicenter RCT (n=1,001), operator radiation exposure was compared between left distal radial vs right transradial access at left wrist, head, and chest. No significant differences. jacc.org/doi/10.1016/j.… #TCT2025 #JACCINT

-Drug-coated balloons for coronary bifurcation lesions -SimoneFezzi et al. explore the role of #DCB as a stent-sparing strategy in bifurcation #PCI, highlighting procedural optimisation, hybrid approaches, and future research needs. eurointervention.pcronline.com/article/drug-c… Tuomas Rissanen

This is how science progresses: when it goes against vested interests, it is not published simultaneously and will be quickly forgotten.

New State-of-the-Art: lesion stratification with intracoronary imaging, from morphology-guided PCI to AI-enabled morphofunctional assessment, outlining the next paradigm shift in interventional cardiology. #InterventionalCardiology #IntracoronaryImaging eurointervention.pcronline.com/article/lesion…